SLAMF1 and inflammatory bowel disease: This study also suggests that CXCL5 and SLAMF1 may act as common pathways of action between facial paralysis and IBD etiology, possibly through mechanisms that regulate immune responses, promote tissue repair, and maintain immune homeostasis.